Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans

Gastroenterology

Volumn 146, Issue 5, 2014, Pages 1313-1324

  Manna, Soumen K ^a   Tanaka, Naoki ^a   Krausz, Kristopher W ^a   Haznadar, Majda ^a   Xue, Xiang ^b   Matsubara, Tsutomu ^a   Bowman, Elise D ^a   Fearon, Eric R ^c   Harris, Curtis C ^a   Shah, Yatrik M ^b   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Azoxymethane; Cancer Biomarker; Colorectal Cancer; Keywords; Metabolic Reprogramming; Metabolomics

Indexed keywords

6 N,N' DIMETHYLARGININE; APC PROTEIN; ARGININE; AZOXYMETHANE; BETA CATENIN; BETAINE; BIOLOGICAL MARKER; GLUTAMIC ACID; N(G),N(G) DIMETHYLARGININE; N1 ACETYLSPERMIDINE; PROLINE; THREONINE; URACIL; XANTHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLORECTAL TUMOR; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION ASSAY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEIC ACID METABOLISM; POLYAMINE METABOLISM; PRIORITY JOURNAL; TISSUE LEVEL; URINE LEVEL;

APC(MIN/+); AZOXYMETHANE; CANCER BIOMARKER; COLORECTAL CANCER; METABOLIC REPROGRAMMING; METABOLOMICS;

ANIMALS; AZOXYMETHANE; CELL PROLIFERATION; CHROMATOGRAPHY, REVERSE-PHASE; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; METABOLOMICS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84899462458     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.01.017     Document Type: Article

References (34)

1. I. Soerjomataram, J. Lortet-Tieulent, and D.M. Parkin et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions Lancet 380 2012 1840 1850
2. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Caner J Clin 62 2012 10 29
3. R.E. Schoen, P.F. Pinsky, and J.L. Weissfeld et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy N Engl J Med 366 2012 2345 2357
4. S.M. Dong, G. Traverso, and C. Johnson et al. Detecting colorectal cancer in stool with the use of multiple genetic targets J Natl Cancer Inst 93 2001 858 865
5. T.F. Imperiale, D.F. Ransohoff, and S.H. Itzkowitz et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population N Engl J Med 351 2004 2704 2714
6. H. Wang, V.K. Tso, and C.M. Slupsky et al. Metabolomics and detection of colorectal cancer in humans: a systematic review Future Oncol 6 2010 1395 1406
7. C. Denkert, J. Budczies, and W. Weichert et al. Metabolite profiling of human colon carcinoma - deregulation of TCA cycle and amino acid turnover Mol Cancer 7 2008 72
8. Y. Qiu, G. Cai, and M. Su et al. Urinary metabonomic study on colorectal cancer J Proteome Res 9 2010 1627 1634
9. Y. Qiu, G. Cai, M. Su, and T. Chen et al. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J Proteome Res 8 2009 4844 4850
10. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
11. S.B. Edge, D.R. Byrd, and C.C. Compton et al. AJCC Cancer Staging Manual 2010 Springer-Verlag New York
12. T. Hinoi, A. Akyol, and B.K. Theisen et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation Cancer Res 67 2007 9721 9730
13. C. Neufert, C. Becker, and M.F. Neurath An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression Nat Protoc 2 2007 1998 2004
14. S.K. Manna, A.D. Patterson, and Q. Yang et al. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model J Proteome Res 10 2011 4120 4133
15. D. Szklarczyk, A. Franceschini, and M. Kuhn et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored Nucleic Acids Res 39 2011 D561 D568
16. Y. Liu, L.S. Zuckier, and N.V. Ghesani Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach Anticancer Res 30 2010 369 374
17. D.R. Wise, R.J. DeBerardinis, and A. Mancuso et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc Natl Acad Sci U S A 105 2008 18782 18787
18. P.S. Ward, and C.B. Thompson Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate Cancer Cell 21 2012 297 308
19. O. Warburg On the origin of cancer cells Science 123 1956 309 314
20. Y. Liu Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer Prostate Cancer Prostatic Dis 9 2006 230 234
21. R.J. DeBerardinis, J.J. Lum, and G. Hatzivassiliou et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell Metab 7 2008 11 20
22. Z. Yang, F. Hollande, and G.S. Baldwin Blockade of long chain fatty acid oxidation by non-steroidal anti-inflammatory drugs may contribute to inhibition of proliferation of human colorectal carcinoma cell lines Cancer Lett 124 1998 187 191
23. J.C. Yoon, A. Ng, and B.H. Kim et al. Wnt signaling regulates mitochondrial physiology and insulin sensitivity Genes Dev 24 2010 1507 1518
24. F. Morrish, J. Noonan, and C. Perez-Olsen et al. Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry J Biol Chem 285 2010 36267 36274
25. L. Li, J.N. Rao, and X. Guo et al. Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation Am J Physiol Cell Physiol 281 2001 C941 C953
26. J.S. Thompson, J.A. Edney, and K. Laughlin Urinary polyamines in colorectal cancer Dis Colon Rectum 29 1986 873 877
27. J.J. Wong, N.J. Hawkins, and R.L. Ward Colorectal cancer: a model for epigenetic tumorigenesis Gut 56 2007 140 148
28. Y. Kondo, and J.P. Issa Epigenetic changes in colorectal cancer Cancer Metastasis Rev 23 2004 29 39
29. J. Wysocka, C.D. Allis, and S. Coonrod Histone arginine methylation and its dynamic regulation Front Biosci 11 2006 344 355
30. M.T. Bedford, and S. Richard Arginine methylation an emerging regulator of protein function Mol Cell 18 2005 263 272
31. B. Cha, W. Kim, and Y.K. Kim et al. Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling Oncogene 30 2011 2379 2389
32. T.S. Weiss, H. Herfarth, and F. Obermeier et al. Intracellular polyamine levels of intestinal epithelial cells in inflammatory bowel disease Inflamm Bowel Dis 10 2004 529 535
33. R. Inoue, M. Miyake, and A. Kanazawa et al. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy Metabolism 28 1979 801 804
34. J. Chen, and X.F. Huang The signal pathways in azoxymethane-induced colon cancer and preventive implications Cancer Biol Ther 8 2009 1313 1317